Brendan M. Everett
Cedars-Sinai Medical Center(US)Brigham and Women's Hospital(US)Harvard University(US)
Publications by Year
Research Areas
Diabetes Treatment and Management, Lipoproteins and Cardiovascular Health, Acute Myocardial Infarction Research, Diabetes Management and Research, Cardiovascular Function and Risk Factors
Most-Cited Works
- → Low-Dose Methotrexate for the Prevention of Atherosclerotic Events(2018)1,264 cited
- → Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk(2022)663 cited
- → Anti-Inflammatory Therapy With Canakinumab for the Prevention of Hospitalization for Heart Failure(2019)615 cited
- → Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19.(2021)586 cited
- → 2020 Expert Consensus Decision Pathway on Novel Therapies for Cardiovascular Risk Reduction in Patients With Type 2 Diabetes(2020)461 cited
- → Lipoprotein(a) Concentrations, Rosuvastatin Therapy, and Residual Vascular Risk(2013)441 cited